Abstract 190: Mesenchymal Stromal Cells (MSCs) Regulate Neutrophil Extracellular Traps (NETs) Through Adenosine
Background: NETs released by neutrophils may be an important component of inflammation in MI/R. NETs consist of extruded DNA, histone, and other chromatin components and are pro-thrombotic and pro-inflammatory. MSCs as a cell therapy for MI/R may act by modulating the innate immune response including NETs. MSCs convert pro-inflammatory ATP into anti-inflammatory adenosine (ADO) via CD 73, a 5’ ectonucleotidase. Objective: To investigate the role of MSCs in regulating NETs through ADO production. Methods: Neutrophils were freshly isolated from peripheral blood of healthy donors. Human bone marrow derived MSCs were grown under standard conditions. Neutrophils were stimulated to produce NETs by PMA (1 μg/ml) and quantified by Sytox green fluorescence. Some neutrophils were also treated with MSCs or ADO. Results: Neutrophils treated with PMA had a 1.9±0.19, (p<0.05) fold increase in NET formation as quantified by Sytox green florescence. Treatment with MSCs in 1:10 ratio prevented increased NET production in response to PMA (1.02±0.12 fold increase). Pretreatment of MSCs with a CD 73 inhibitor APCP reduced their ability to prevent NET formation in some donors (1.62±0.10). ADO decreased NET formation in a dose dependent manner. Conclusion: MSCs may inhibit NET formation through ADO signaling and could be an important mechanism of MSC anti-inflammatory effects in MI/R. Future studies will investigate the ability of MSCs to inhibit NET formation in MI/R.